Stage IIIB Breast Cancer Completed Phase 2 Trials for Zoledronic acid (DB00399)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01194440Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal SymptomsSupportive Care